Ocular Gene Therapy


Ocular gene therapy has made a rapid progress in the past few years. This method directly administered into the eye, targeting diseases caused by mutations in the gene RPE65. Mutations in ths gene can produce Retinitis Pigmentosa, a rare but potentially Blinding diseases.


  • Gene replacement
  • DNA Nanoparticle
  • RNA Interference
  • Ex vivo for Retinal Pigmentosa

Related Conference of Ocular Gene Therapy

April 25-26, 2024

24th Global Ophthalmologists Annual Meeting

London, UK
May 09-10, 2024

7th International Eye and Vision Congress

Barcelona, Spain
May 16-17, 2024

8th World Congress on Eye and Vision

Rome, Italy
June 13-14, 2024

9th International Conference on Eye and Vision

Barcelona, Spain
September 12-13, 2024

5th International Conference on Optometry

Paris, France
October 10-11, 2024

34th World Congress on Ophthalmology and Optometry

Madrid, Spain
October 10-11, 2024

10th Global Ophthalmology Meeting

Madrid, Spain

Ocular Gene Therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in